Scientific Reports, 2024 · DOI: 10.1038/s41598-024-69861-y · Published: August 9, 2024
This study explores the use of cold atmospheric plasma (CAP) to treat spinal cord injuries (SCI). CAP is a type of plasma that doesn't cause thermal damage to tissues and has no toxic side effects, making it potentially useful for treating neurological diseases. The researchers used a device called a dielectric barrier discharge (DBD) to apply CAP to the injured spinal cords of mice. They found that CAP treatment improved functional recovery after SCI, reduced neuronal apoptosis, lowered inflammation, and increased axonal regeneration. The study also found that CAP treatment can reduce oxidative stress and trigger the self-antioxidant capability of tissues. This suggests that CAP could help protect nerve cells from damage and promote their regeneration after a spinal cord injury.
CAP presents a novel therapeutic approach for managing SCI, offering potential improvements in neural recovery.
The research findings pave the way for innovative treatments in neurodegenerative disease management, expanding the application of CAP technology.
Further studies are warranted to translate these findings into clinical applications, potentially leading to new treatment protocols for SCI patients.